CORSAIR PHARMA
Corsair Pharma is developing transformative solutions to the therapeutic profile of medications and provide superior treatment for patients.
CORSAIR PHARMA
Social Links:
Website Url:
http://www.corsairpharma.com
Status:
Active
Email Addresses:
[email protected]
Current Advisors List
Current Employees Featured
Official Site Inspections
http://www.corsairpharma.com
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Corsair Pharma"
Corsair Pharma | HOME | Developing Improved …
Corsair Pharma is developing transformative solutions to improve the therapeutic profile of medications and provide superior treatment options for patients.See details»
Corsair Pharma - Crunchbase Company Profile & Funding
Corsair Pharma is developing transformative solutions to the therapeutic profile of medications and provide superior treatment for patients.See details»
Corsair Pharma 2025 Company Profile: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Corsair Pharma. Use the PitchBook Platform to explore the full profile.See details»
Corsair Pharma - LinkedIn
Corsair Pharma is developing transformative solutions to improve the therapeutic profile of medications and provide superior treatment options for patients. The company is focused on the ...See details»
Corsair Pharma | TEAM
The Corsair Pharma Team is developing transformative solutions to improve the therapeutic profile of medications and provide superior treatment options for patients.See details»
Corsair Pharma, Inc. - VentureRadar
"Corsair Pharma is developing transformative solutions to improve the therapeutic profile of medications and provide superior treatment options for patients. The company’s first product …See details»
Corsair Pharma, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
SUNNYVALE, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Corsair Pharma, Inc., a private biopharmaceutical company developing a transdermal treprostinil prodrug, today announced …See details»
Corsair Pharma - Overview, News & Similar companies - ZoomInfo
Dec 10, 2023 View Corsair Pharma (www.corsairpharma.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Corsair Pharma Company Profile: Overview and Full News Analysis
Corsair Pharma focuses on the Pharmaceuticals sector. Explore the world of Startups and Venture Investing at OurCrowd.See details»
Corsair Pharma | PRIVACY
Corsair Pharma is developing transformative solutions to improve the therapeutic profile of medications and provide superior treatment options for patients.See details»
Corsair Pharma Announces $23 Million Series B Financing to …
SUNNYVALE, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Corsair Pharma, Inc., a private biopharmaceutical company developing a transdermal treprostinil prodrug, today announced …See details»
George Mahaffey - Chief Executive Officer - Crunchbase
George Mahaffey is the Chief Executive Officer of Corsair Pharma. He previously worked at Clarify Medical, Inc. as a President and CEO. George Mahaffey attended the University of …See details»
Corsair Pharma Announces $23 Million Series B Financing to …
SUNNYVALE, Calif.,September 20, 2023 -- Corsair Pharma, Inc., a private biopharmaceutical company developing a transdermal treprostinil prodrug, today announced the closing of its $23 …See details»
Corsair Pharma, Inc. to Present at LifeSci Partners Annual
Jul 15, 2021 Corsair Pharma, Inc. to Present at LifeSci Partners Annual Private Company Summer Symposium July 15, 2021 08:00 ET | Source: Corsair Pharma, Inc.See details»
Corsair & United Therapeutics Enter Strategic ... - Corsair Pharma
Jan 3, 2018 SOUTH SAN FRANCISCO, Calif. and SILVER SPRING, Md., Jan. 3, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR), a leading biotechnology …See details»
Simplification for success: Rewiring the biopharma operating …
22 hours ago Less than a third of the 50 leaders we surveyed believe their organization currently possesses the talent and capabilities required to support future product portfolios, including …See details»
Corsair Pharma | NEWS & EVENTS
Jun 24, 2021 Corsair Pharma is in the news developing transformative solutions to improve the therapeutic profile of medications and provide superior treatment options for patients.See details»
Nutraceutical Contract Manufacturer in Canada | CSN Pharma
Grow with CSN Pharma - A leading Canadian Supplement Manufacturer in Vancouver. GMP & SQF certified, compliant with Health Canada, CFIA, and FDA standards.See details»
Corsair Pharma Announces $23 Million Series B Financing to
Sep 20, 2023 Corsair Pharma Announces $23 Million Series B Financing to Advance Clinical Trials in Pulmonary Arterial Hypertension September 20, 2023 08:00 ET | Source: Corsair …See details»
Corsair Pharma Announces Successful Completion of Preclinical …
4 days ago Preparation for Phase 1 Trial Underway with Expected Start in Q2 2025 NEWARK, Calif., March 17, 2025 – Corsair Pharma, Inc., a private biopharmaceutical company today …See details»